Concepedia

N. N. Girotra

NN

Statistics

Publications

20

Citations

577

H-Index

13

Active since

1963

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

N. N. Girotra is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, organic chemistry, and natural sciences.

Publications per year

1963–2005

20

Publications

20

Total synthesis of the macrolide, zearalenone

D. Taub, N. N. Girotra, R. D. Hoffsommer et al. · Tetrahedron · 1968 · 117 citations

, , +12

Total synthesis of dl-cedrene and dl-cedrol

E. J. Corey, N. N. Girotra, C. Thomas Mathew · Journal of the American Chemical Society · 1969 · 69 citations

, , +6

Inhibition of Stromelysin-1 (MMP-3) by P<sub>1</sub>‘-Biphenylylethyl Carboxyalkyl Dipeptides

Craig K. Esser, Robert L. Bugianesi, Charles G. Caldwell et al. · Journal of Medicinal Chemistry · 1997 · 66 citations · Full text

, , +10

Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents

Tesfaye Biftu, Dennis Feng, Mitree M. Ponpipom et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 53 citations · Full text

, , +12

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester

N. N. Girotra, Tesfaye Biftu, Mitree M. Ponpipom et al. · Journal of Medicinal Chemistry · 1992 · 29 citations · Full text

, , +7

1–5 of 20